BUDESONIDE
Identification of Budesonide
| No description |
Google image searchProduct monograph
Active ingredient
budesonide, 3 MG
DIN: 02483874
Dosage form(s): CAPSULE (SUSTAINED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: TILLOTTS PHARMA GMBH
Date: 20-JUL-2022
ATC:
- A07 — ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (ATC, ATC/DDD, )
- A07E — INTESTINAL ANTIINFLAMMATORY AGENTS (ATC, ATC/DDD)
- A07EA — Corticosteroids acting locally (ATC, ATC/DDD)
- A07EA06 — BUDESONIDE (ATC/DDD)
Reference brand drug: Jorveza, Entocort
